Going even smaller: Engineering sub‐5 nm nanoparticles for improved delivery, biocompatibility, and functionality
Authors:
- 20 May 2020
- journal article
- review article
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 12 (6) , e1644
Abstract
The rapid development and advances in nanomaterials and nanotechnology in the past two decades have made profound impact in our approaches to individualized disease diagnosis and treatment. Nanomaterials, mostly in the range of 10–200 nm, developed for biomedical applications provide a wide range of platforms for building and engineering functionalized structures, devices, or systems to fulfill the specific diagnostic and therapeutic needs. Driven by achieving the ultimate goal of clinical translation, sub‐5 nm nano‐constructs, in particular inorganic nanoparticles such as gold, silver, silica, and iron oxide nanoparticles, have been developed in recent years to improve the biocompatibility, delivery and pharmacokinetics of imaging probes and drug delivery systems, as well as in vivo theranostic applications. The emerging studies have provided new findings that demonstrated the unique size‐dependent physical properties, physiological behaviors and biological functions of the nanomaterials in the range of the sub‐5 nm scale, including renal clearance, novel imaging contrast, and tissue distribution. This advanced review attempts to introduce the new strategies of rational design for engineering nanoparticles with the core sizes under 5 nm in consideration of the clinical and translational requirements. We will provide readers the update on recent discoveries of chemical, physical, and biological properties of some biocompatible sub‐5 nm nanomaterials as well as their demonstrated imaging and theranostic applications, followed by sharing our perspectives on the future development of this class of nanomaterials.This article is categorized under: Diagnostic Tools > in vivo Nanodiagnostics and Imaging Implantable Materials and Surgical Technologies > Nanomaterials and ImplantsKeywords
Funding Information
- National Institutes of Health (1U01CA19891301, R01CA154846‐04, U01CA151810‐05)
This publication has 117 references indexed in Scilit:
- Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic NanoparticlesTheranostics, 2012
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on sizeNature Nanotechnology, 2011
- Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanomaJournal of Clinical Investigation, 2011
- Effects of Nanoparticle Size on Cellular Uptake and Liver MRI with Polyvinylpyrrolidone-Coated Iron Oxide NanoparticlesACS Nano, 2010
- A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide LigandsACS Nano, 2010
- Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticlesProceedings of the National Academy of Sciences, 2009
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Sub 5 nm magnetite nanoparticles: Synthesis, microstructure, and magnetic propertiesMaterials Letters, 2007
- Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and ShapesNano Letters, 2007
- Nanoparticle Imaging of Integrins on Tumor CellsNeoplasia, 2006